Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein–1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease-Reference-Cited by-同舟云学术

Oxysterol sulfation by cytosolic sulfotransferase suppresses liver X receptor/sterol regulatory element binding protein–1c signaling pathway and reduces serum and hepatic lipids in mouse models of nonalcoholic fatty liver disease

Published:2012-06 Issue:6 Volume:61 Page:836-845
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Bai Qianming,Zhang Xin,Xu Leyuan,Kakiyama Genta,Heuman Douglas,Sanyal Arun,Pandak William M.,Yin Lianhua,Xie Wen,Ren Shunlin

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference38 articles.

1. Nonalcoholic fatty liver disease;Clark;Gastroenterology,2002

2. The epidemiology of nonalcoholic fatty liver disease: a global perspective;Lazo;Semin Liver Dis,2008

3. Nonalcoholic steatohepatitis;Brunt;Semin Liver Dis,2004

4. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus;Leite;Liver Int,2009

5. Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease;Miller;Liver Int,2011

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human sulfotransferase SULT2B1 physiological role and the impact of genetic polymorphism on enzyme activity and pathological conditions;Frontiers in Genetics;2024-08-30

2. Larsucosterol: endogenous epigenetic regulator for treating chronic and acute liver diseases;American Journal of Physiology-Endocrinology and Metabolism;2024-05-01

3. Lipid sensing nuclear receptors involved in the pathogenesis of fatty liver disease;FEBS Letters;2024-02-13

4. Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivo;American Journal of Physiology-Gastrointestinal and Liver Physiology;2024-02-01

5. SREBPs as the potential target for solving the polypharmacy dilemma;Frontiers in Physiology;2024-01-10